ddie is a Partner at Pear VC, where he leads the firm’s investments in innovative life sciences companies.
Eddie’s background combines deep scientific and business experience in biotechnology. Eddie received his PhD in Biological Engineering from MIT. Under the guidance of Professors Robert Langer and Daniel Anderson, Eddie’s doctoral studies focused on the development of non-viral gene therapies, and his research efforts contributed to 14 peer-reviewed journal publications. After MIT, Eddie joined an early-stage ocular drug delivery company, where he worked as a scientist on formulation development and process scale-up for two clinical drug products that went on to receive FDA approval.
Eddie then pursued his MBA at the Stanford University Graduate School of Business, where he completed internships in business development at Roche/Genentech and in venture capital at NanoDimension. Most recently, Eddie served as Head of Corporate Development at Senti Bio, a Pear portfolio company leveraging synthetic biology for next-generation cell and gene therapies. Eddie joined as the company’s first business hire and contributed to partnering, fundraising, product strategy, external communications, and alliance management, as the company advanced from seed stage through to a public financing. Additionally, he helped drive the execution of two major biopharma collaborations with Spark Therapeutics (Roche) and BlueRock Therapeutics (Bayer).
Eddie is passionate about the clinical and commercial translation of cutting-edge life sciences technologies, and he loves working to support visionary founders on their missions to transform human health.
Eddie and his wife both grew up and live in the Bay Area, and they spend much of their free time attempting to keep their two young boys entertained. Eddie enjoys playing tennis as well as tinkering on various musical instruments, including the piano and drums.